Risk factors for cardiac injury in patients with ischaemic stroke: a retrospective analysis

Hui Tang1, Mengyuan Li2, Zhi Liu1

  • 1Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China.

Frontiers in Neurology
|December 19, 2025
PubMed

Insights

This study found that Glasgow Coma Scale scores and blood urea nitrogen levels are not independent predictors of cardiac injury in ischemic stroke patients. Early risk identification and monitoring are crucial for improving patient outcomes.

Area of Science:

  • Cardiology
  • Neurology
  • Biochemistry

Background:

  • Cardiac injury (CI) is a concern in patients with ischemic stroke (IS).
  • Identifying independent risk factors for CI is crucial for timely intervention.
  • Previous studies suggest associations, but independent predictors require clarification.

Purpose of the Study:

  • To identify independent risk factors for cardiac injury (CI) in patients with ischemic stroke (IS).
  • To provide evidence for early screening and intervention strategies for CI in IS patients.

Main Methods:

  • A single-center retrospective study analyzed 393 hospitalized IS patients.
  • Patients were classified into CI and non-CI groups based on cardiac biomarkers and ECG/echocardiographic findings.
  • Multivariate logistic regression was used to identify independent risk factors for CI.

Main Results:

  • Univariate analysis showed significant differences in age, cardiac biomarkers, inflammatory markers, renal function, coagulation markers, and comorbidities between groups.
  • Multivariate analysis revealed that Glasgow Coma Scale scores and blood urea nitrogen levels were not statistically significant independent predictors of CI in IS patients.
  • 100 out of 393 patients experienced cardiac injury.

Conclusions:

  • Glasgow Coma Scale scores and blood urea nitrogen levels, while associated, are not independent predictors of cardiac injury in ischemic stroke.
  • A clear operational definition of CI is essential for consistent diagnosis and early risk identification.
  • Enhanced screening, monitoring, and biomarker evaluation are vital for optimizing early management and improving outcomes in IS patients with potential CI.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
197
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
993
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
758
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
660